We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

IMMNOV

OMX
Main market
Access this stock data via API
Subscribe
Immunovia AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 931K 1.6M 1.1M 844K
Cost of revenue 0 6.7M 4.2M -15.0M
Gross profit 931K -5.1M -3.1M 15.8M
Operating expense
Research & development
Selling general and admin 82.6M
Other operating expenses 68.6M 70.3M 78.0M 84.0M
Operating income -109.4M -296.6M -191.2M -166.7M
Non operating interest income
Income 34.7M 2.9M 745K 710K
Expense 1.9M 1.2M 1.6M 1.4M
Other income expense
Pretax income -76.5M -309.4M -168.1M -156.0M
Tax provision 0 0 0 0
Net income -76.5M -309.4M -168.1M -156.0M
Basic EPS -0.9 -3.7 -3.4 -3.2
Diluted EPS -0.9 -3.7 -3.4 -3.2
Basic average shares 82.6M 84.4M 49.1M 49.1M
Diluted average shares 82.6M 84.4M 49.1M 49.1M
EBITDA -61.3M -166.6M -141.6M -135.5M
Net income from continuing op. -109.4M -296.5M -191.2M -166.6M
Minority interests
Preferred stock dividends 0 0 0 0
Main market

Exchange is currently active.
Closing in 1 hour 2 minutes

16:27
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).